Your search returned 7 results.

Results
	1.	Probabilities, costs, and outcomes: methodological issues in modelling haemophilia treatment. [electronic resource] by Bohn, R L Colowick, A B Avorn, J Producer: 20000218 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper. [electronic resource] by Colowick, A B Bohn, R L Avorn, J Ewenstein, B M Producer: 20001018 In: Blood vol. 96 Availability: No items available. Save to lists Add to cart (remove)
	3.	Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study. [electronic resource] by Kotasek, D Steger, G Faught, W Underhill, C Poulsen, E Colowick, A B Rossi, G Mackey, J Producer: 20031023 In: European journal of cancer (Oxford, England : 1990) vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer. [electronic resource] by Smith, R E Tchekmedyian, N S Chan, D Meza, L A Northfelt, D W Patel, R Austin, M Colowick, A B Rossi, G Glaspy, J Producer: 20030808 In: British journal of cancer vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy. [electronic resource] by Glaspy, J A Jadeja, J S Justice, G Kessler, J Richards, D Schwartzberg, L Tchekmedyian, N S Armstrong, S O'Byrne, J Rossi, G Colowick, A B Producer: 20020910 In: British journal of cancer vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer. [electronic resource] by Smith, R E Jaiyesimi, I A Meza, L A Tchekmedyian, N S Chan, D Griffith, H Brosman, S Bukowski, R Murdoch, M Rarick, M Saven, A Colowick, A B Fleishman, A Gayko, U Glaspy, J Producer: 20010906 In: British journal of cancer vol. 84 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. [electronic resource] by Glaspy, J Jadeja, J S Justice, G Kessler, J Richards, D Schwartzberg, L Rigas, J Kuter, D Harmon, D Prow, D Demetri, G Gordon, D Arseneau, J Saven, A Hynes, H Boccia, R O'Byrne, J Colowick, A B Producer: 20010906 In: British journal of cancer vol. 84 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)